Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study.
about
Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisitedInvasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies.Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or olderPrevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?Rethinking recommendations for use of pneumococcal vaccines in adults.Effect of the conditional cash transfer program Oportunidades on vaccination coverage in older Mexican peoplePneumococcal vaccination and revaccination of older adults.Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.Immune profile of asplenic patients following single or double vaccine administration: A longitudinal cross-sectional study.Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention.Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in SpainEffect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity.Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study.Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease.Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional studyVaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes.Pneumococcal vaccination in hospitalized elderly patients: role of the pharmacist.
P2860
Q24803495-7DAB4E41-9934-4533-BF03-125007CED523Q33353828-4B510ED1-E40A-4D42-B1C1-06FBB4B727DDQ33542866-4F6D3233-CDBC-43DE-91F4-87F33CF13806Q33955782-935448D9-C555-4C45-83D0-94684A7242AAQ34326459-11D782BE-5A92-42EA-BADB-F251D7D1CE7FQ34802890-E57219ED-EF15-42A6-BF0A-12983A936E26Q34926870-BD1FAFFA-71DF-46CD-AFA2-F97908DE215DQ35533941-2D623490-E03C-4B7E-A045-617D9C7F6815Q36160043-9532441C-69BC-4BEA-8320-689B5EC9C34AQ36257961-4A8921AB-F87D-482B-85A4-09CACEDEBC80Q36277159-D368728A-AB7A-4FEF-B8FC-75308BF427FBQ36665557-9D05031C-E77C-4CCD-8C34-012871155729Q36887932-EACB53C0-04AE-457B-8DBE-01FCC59B4FB9Q37093763-68D0AF7F-CC1C-49C7-968B-AF5F1C818384Q37135413-366E8941-754D-4396-AD34-A69A88ADD3C1Q37197138-57305CB3-1A0E-4588-8A50-F6CBD15CD7CEQ46161480-2F23E3D5-0FCE-41BA-B26C-067C866BC535
P2860
Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study.
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Preventing pneumococcal bacter ...... a matched case-control study.
@ast
Preventing pneumococcal bacter ...... a matched case-control study.
@en
type
label
Preventing pneumococcal bacter ...... a matched case-control study.
@ast
Preventing pneumococcal bacter ...... a matched case-control study.
@en
prefLabel
Preventing pneumococcal bacter ...... a matched case-control study.
@ast
Preventing pneumococcal bacter ...... a matched case-control study.
@en
P2093
P1476
Preventing pneumococcal bacter ...... a matched case-control study.
@en
P2093
Germanson TP
Johnston BL
P304
P356
10.1001/ARCHINTE.155.21.2336
P407
P577
1995-11-01T00:00:00Z